论文部分内容阅读
在过去的10年期间。大量的临床观察报道曾提出别嘌呤醇(allopurinol)药物与人体白内障之间可能相关。为此,作者从光谱学角度进行研究,以确定所有因痛风而长期服用此药的患者在白内障与无白内障性晶体之间是否有任何差异。本文包括11例至少服用别嘌呤醇2年的病例,年龄自55至84岁。通过白内障摘出术(包括由囊外摘出所吸出的晶体物质)检查了11只白内障性晶体,并将这些晶体与4只无白内障的晶体作比
During the past 10 years. A large number of clinical observations have suggested that allopurinol may be associated with cataract in the human body. To do this, the authors conducted a study from a spectroscopic point of view to determine if there was any difference between cataract and no cataract crystals in all patients who had been taking this medicine for a long time due to gout. This article includes 11 cases of at least 2 years of allopurinol cases, aged 55 to 84 years old. Eleven cataractous lenses were examined by cataract extraction (including aspirated material from extracapsular cataracts) and compared to four cataract-free crystals